Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. European Lung Cancer Congress 2025

Pfizer - Promising new targets and ADCs in development for NSCLC

What’s next in NSCLC? New targets and ADC innovations

Date

28 Mar 2025

Session

Pfizer - Promising new targets and ADCs in development for NSCLC

Presenters

Anna Minchom

Authors

A.R. Minchom

Author affiliations

  • Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton/GB

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome and Introduction

Presenter: David Planchard

Session: Pfizer - Promising new targets and ADCs in development for NSCLC

Resources:

Webcast

Conclusions and panel discussion

Presenter: David Planchard, Anna Minchom

Session: Pfizer - Promising new targets and ADCs in development for NSCLC

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.